Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • Remdesivir

Tag: Remdesivir

  • BiotechToday
  • World

VV116 vs. Nirmatrelvir-Ritonavir Against COVID-19

DNA tales April 23, 2023April 23, 2023

Tholkappian R, NIT Durgapur Nirmatrelvir is an oral inhibitor of the SARS-CoV-2’s, 3-chymotrypsin–like cysteine protease, while VV116 is a deuterated remdesivir hydro-bromide with potent activity against SARS-CoV-2. Nirmatrelvir-ritonavir was used to treat COVID-19 of low to moderate severity. However, its production could not meet the global supply demands. VV116 is one such oral analog of […]

Read More
  • Biotechnopedia
  • DNA-Tales

Neurological Effects in COVID-19 Patients

DNA tales August 9, 2021August 9, 2021

Aayushi Gaur, U. I. E. T., Kurukshetra University Doctors battled to keep patients breathing in the early months of the COVID-19 pandemic, focusing mostly on treating lung and circulatory system damage. However, evidence of neurological consequences was already collecting at the time. Some COVID-19 patients were suffering from delirium, which manifested as confusion, disorientation, and […]

Read More
  • BiotechToday
  • World

Shionogi is in a race against Pfizer and Merck

BioTech Today August 4, 2021August 4, 2021 2

Sneha Singhal, Jaypee Institute of information technology, Noida Pfizer Inc. and Merck & Co. in the race to find treatments for Covid-19 have joined a Japanese company in starting human trials for the first once-daily pill. Shionogi and Co., of Osaka, claimed that its pill would neutralize the Coronavirus in five days or less. The […]

Read More
  • BiotechToday
  • India

Drugs like ivermectin, doxycycline, Hydroxychloroquine removed in revised Covid-19 guidelines

BioTech Today June 14, 2021June 14, 2021 1

Saptaparna Pal, Amity University Kolkata The Union Health Ministry’s Directorate General of Health Sciences (DGHS) has proposed revised Covid-19 guidelines and removed all medicines except antipyretic (fever) and antitussive (cold) for mild and asymptomatic cases. The revised Covid-19 guidelines issued on 27 May 2021 dropped all medicines that the doctors have been prescribing even to […]

Read More
  • BiotechToday
  • World

Remdesivir resistant SARS-CoV-2!

bioxone January 6, 2021January 5, 2021 1

Parnad Basu, Amity University Kolkata Remdesivir (C27H35N6O8P), is a broad-spectrum antiviral medication. It is administered via injection into a vein. Before the completion of clinical trials of the COVID-19 vaccines, remdesivir will be used to fight COVID-19. Now, COVID-19 is always mutating. And it is important to study those mutations to make remdesivir more effective […]

Read More
  • BiotechToday
  • World

Neutrophil-derived Nanovesicles: A Novel Drug Delivery System

bioxone December 13, 2020December 12, 2020 3

Sayak Banerjee. Amity University Kolkata Scientists at Washington State University (WSU) discovered that other than immune cells, neutrophils also might play a major role in defense against infection, through a new drug delivery technology. Neutrophils are the most common type of white blood cells (WBCs) that lead the body’s immune system response. They established a […]

Read More
  • BiotechToday
  • World

Lapatinib, Doramapimod with Remdesivir teamed against COVID-19

bioxone December 1, 2020December 1, 2020 1

Souradip Mallick, National Institute of Technology, Rourkela The emergence of SARS-CoV-2 virus has resulted in a worldwide pandemic killed over 1,368,000 people globally (WHO). Currently, effective treatments to inhibit SARS-CoV-2 morbidity and mortality are not available. The pharmacological screen identified several compounds capable of blocking the in vitro replication of two beta-coronaviruses. Among many ones […]

Read More

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy